title: Oxcarbazepine for self-mutilating bulimic patients.
authors.forename: Táki Athanassios
authors.initials: TA
authors.lastname: Cordás
authors.forename: Hermano
authors.initials: H
authors.lastname: Tavares
authors.forename: Douglas Motta
authors.initials: DM
authors.lastname: Calderoni
authors.forename: Gabriela Viegas
authors.initials: GV
authors.lastname: Stump
authors.forename: Rafael Bernardon
authors.initials: RB
authors.lastname: Ribeiro
mesh_terms: D000328:Adult; D000437:Alcoholism / Q000150:complications / Q000523:psychology; D000856:Anorexia Nervosa / Q000150:complications / Q000523:psychology; D000927:Anticonvulsants / Q000627:therapeutic use*; D001883:Borderline Personality Disorder / Q000188:drug therapy / Q000523:psychology; D002032:Bulimia / Q000150:complications / Q000188:drug therapy* / Q000523:psychology; D002220:Carbamazepine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007174:Disruptive, Impulse Control, and Conduct Disorders / Q000150:complications / Q000523:psychology; D005260:Female; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000150:complications / Q000523:psychology; D000078330:Oxcarbazepine; D011569:Psychiatric Status Rating Scales; D012652:Self Mutilation / Q000150:complications / Q000188:drug therapy* / Q000523:psychology; D019966:Substance-Related Disorders / Q000150:complications / Q000523:psychology
chemical_list: D000927:Anticonvulsants; D002220:Carbamazepine; D000078330:Oxcarbazepine